Clinical features of immune-related thyroid dysfunction and its association with outcomes in patients with advanced malignancies treated by PD-1 blockade

Programmed cell death protein-1 (PD-1) blockade therapy has improved outcomes in the treatment of advanced cancers. The therapy is well-tolerated, although it occasionally causes immune-related adverse events (irAEs). Thyroid dysfunction is one of the most common irAEs seen. Our aim was to clarify t...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
الحاوية / القاعدة:Oncol Lett
المؤلفون الرئيسيون: Sakakida, Tomoki, Ishikawa, Takeshi, Uchino, Junji, Chihara, Yusuke, Komori, Satoshi, Asai, Jun, Narukawa, Tsukasa, Arai, Akihito, Kobayashi, Tsutomu, Tsunezuka, Hiroaki, Kosuga, Toshiyuki, Konishi, Hirotaka, Hongo, Fumiya, Inoue, Masayoshi, Hirano, Shigeru, Ukimura, Osamu, Itoh, Yoshito, Taguchi, Tetsuya, Takayama, Koichi
التنسيق: Artigo
اللغة:Inglês
منشور في: D.A. Spandidos 2019
الموضوعات:
Articles
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC6607381/
https://ncbi.nlm.nih.gov/pubmed/31423288
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2019.10466
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة